Interacting Drugs |
Prednisolone (systemic) vs Neuromuscular-Blocking Agents (Nondepolarizing) |
Security Level |
 |
Mechanism |
Neuromuscular-Blocking Agents (Nondepolarizing): May enhance the adverse neuromuscular effect of Corticosteroids (Systemic). Increased muscle weakness, possibly progressing to polyneuropathies and myopathies, may occur. |
Management |
Consider therapy modification |
Prednisolone (systemic) vs Neuromuscular-Blocking Agents (Nondepolarizing)
Post Review about Prednisolone (systemic) vs Neuromuscular-Blocking Agents (Nondepolarizing) Click here to cancel reply.
Other Interactions of Prednisolone (systemic)
Other Interactions of Neuromuscular-Blocking Agents (Nondepolarizing)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.